| Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial J Kahn, S Lagakos, M Wulfsohn, D Cherng, M Miller, J Cherrington, ... Jama 282 (24), 2305-2312, 1999 | 266 | 1999 |
| Survival and disease progression according to gender of patients with HIV infection: the Terry Beirn Community Programs for Clinical Research on AIDS SL Melnick, R Sherer, TA Louis, D Hillman, EM Rodriguez, C Lackman, ... Jama 272 (24), 1915-1921, 1994 | 266 | 1994 |
| Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2 ‘structure− activity relationship, and molecular recognition of cyclic ureas PYS Lam, Y Ru, PK Jadhav, PE Aldrich, GV DeLucca, CJ Eyermann, ... Journal of medicinal chemistry 39 (18), 3514-3525, 1996 | 258 | 1996 |
| Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic … LD Saravolatz, DL Winslow, G Collins, JS Hodges, C Pettinelli, DS Stein, ... New England Journal of Medicine 335 (15), 1099-1106, 1996 | 247 | 1996 |
| Characterization of human immunodeficiency virus type 1 mutantswith decreased sensitivity to proteinase inhibitor Ro 31-8959 H Jacobsen, K Yasargil, DL Winslow, JC Craig, A Kröhn, IB Duncan, ... Virology 206 (1), 527-534, 1995 | 240 | 1995 |
| Infectious Diseases Society of America (IDSA) position statement: why IDSA did not endorse the surviving sepsis campaign guidelines IDSA Sepsis Task Force Kalil Andre C Gilbert David N Winslow Dean L Masur ... Clinical Infectious Diseases 66 (10), 1631-1635, 2018 | 187 | 2018 |
| Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450 CN Hodge, PE Aldrich, LT Bacheler, CH Chang, CJ Eyermann, S Garber, ... Chemistry & biology 3 (4), 301-314, 1996 | 178 | 1996 |
| In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. MJ Otto, S Garber, DL Winslow, CD Reid, P Aldrich, PK Jadhav, ... Proceedings of the National Academy of Sciences 90 (16), 7543-7547, 1993 | 162 | 1993 |
| Accuracy of the TRUGENE HIV-1 Genotyping Kit RM Grant, DR Kuritzkes, VA Johnson, JW Mellors, JL Sullivan, ... Journal of clinical microbiology 41 (4), 1586-1593, 2003 | 156 | 2003 |
| Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure C Rhee, K Chiotos, SE Cosgrove, EL Heil, SS Kadri, AC Kalil, DN Gilbert, ... Clinical Infectious Diseases 72 (4), 541-552, 2021 | 140 | 2021 |
| Rhodococcus equi Infection in the Patient with AIDS: Literature Review and Report of an Unusual Case W Emmons, B Reichwein, DL Winslow Reviews of infectious diseases 13 (1), 91-96, 1991 | 137 | 1991 |
| Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial P Jagannathan, JR Andrews, H Bonilla, H Hedlin, KB Jacobson, ... Nature Communications 12 (1), 1967, 2021 | 129 | 2021 |
| HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms J Ravela, BJ Betts, F Brun-Vézinet, AM Vandamme, D Descamps, ... Journal of acquired immune deficiency syndromes (1999) 33 (1), 8, 2003 | 125 | 2003 |
| Performance Characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System DR Kuritzkes, RM Grant, P Feorino, M Griswold, M Hoover, R Young, ... Journal of clinical microbiology 41 (4), 1594-1599, 2003 | 99 | 2003 |
| Aphthous ulceration of the gastrointestinal tract in patients with the acquired immunodeficiency syndrome (AIDS) MC Bach, DA Howell, AJ Valenti, TJ Smith, DL Winslow Annals of internal medicine 112 (6), 465-467, 1990 | 91 | 1990 |
| Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin DL Winslow, J Damme, E Dieckman Antimicrobial Agents and Chemotherapy 23 (4), 555-558, 1983 | 82 | 1983 |
| In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes DL Winslow, GA Pankey Antimicrobial Agents and Chemotherapy 22 (1), 51-54, 1982 | 71 | 1982 |
| Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. DL Winslow, S Garber, C Reid, H Scarnati, D Baker, MM Rayner, ... AIDS (London, England) 10 (11), 1205-1209, 1996 | 70 | 1996 |
| Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor—experienced persons J Lawrence, J Schapiro, M Winters, J Montoya, A Zolopa, R Pesano, ... The Journal of infectious diseases 179 (6), 1356-1364, 1999 | 67 | 1999 |
| Limited Sequence Diversity of the HIV Type 1 Protease Gene from Clinical Isolates and in Vitro Susceptibility to HIV Protease Inhibitors DL WINSLOW, S STACK, R KING, H SCARNATI, A BINCSIK, MJ OTTO AIDS research and human retroviruses 11 (1), 107-113, 1995 | 63 | 1995 |
